COYA, Dr. Reddys Sign Deal for Proposed Abatacept Biosimilar - Nasdaq
APTXDelisted Stock | USD 0.07 0.01 16.67% |
Slightly above 55% of Aptinyx's investors are presently thinking to get in. The analysis of current outlook of investing in Aptinyx suggests that some traders are interested regarding Aptinyx's prospects. Aptinyx's investor sentiment overview provides quick insight into current market opportunities from investing in Aptinyx. The current market sentiment, together with Aptinyx's historical and current headlines, can help investors time the market. In addition, many technical investors use Aptinyx stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Aptinyx stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Aptinyx daily returns and investor perception about the current price of Aptinyx as well as its diversification or hedging effects on your existing portfolios.
Aptinyx |
COYA, Dr. Reddys Sign Deal for Proposed Abatacept Biosimilar Nasdaq
Read at news.google.com
Aptinyx Fundamental Analysis
We analyze Aptinyx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aptinyx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aptinyx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Aptinyx is currently under evaluation in total asset category among related companies. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Aptinyx Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aptinyx stock to make a market-neutral strategy. Peer analysis of Aptinyx could also be used in its relative valuation, which is a method of valuing Aptinyx by comparing valuation metrics with similar companies.
Peers
Aptinyx Related Equities
RNAZ | Transcode Therapeutics | 15.49 | ||||
QNRX | Quoin Pharmaceuticals | 6.34 | ||||
ACHL | Achilles Therapeutics | 3.04 | ||||
ASMB | Assembly Biosciences | 2.65 | ||||
NRBO | Neurobo Pharmaceuticals | 1.34 | ||||
SPRO | Spero Therapeutics | 1.24 | ||||
TIL | Instil Bio | 0.71 | ||||
VRAX | Virax Biolabs | 0.64 | ||||
RVPH | Reviva Pharmaceuticals | 0.63 | ||||
ATXI | Avenue Therapeutics | 0.21 | ||||
NUVB | Nuvation Bio | 1.53 | ||||
CTMX | CytomX Therapeutics | 1.56 | ||||
ALRN | Aileron Therapeutics | 1.57 | ||||
ADIL | Adial Pharmaceuticals | 5.03 | ||||
ABVC | ABVC Biopharma | 6.09 | ||||
ADTX | Aditxt | 6.88 | ||||
ALLR | Allarity Therapeutics | 18.70 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Aptinyx Stock
If you are still planning to invest in Aptinyx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aptinyx's history and understand the potential risks before investing.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |